- The key vendors in the Global Pediatric Vaccines Market 2014-2018 are GlaxoSmithKline plc, Merck and Co., Pfizer Inc. and Sanofi
London, 08 October 2014: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global Pediatric Vaccines Market 2014-2018. One key trend upcoming in this market is the strategic alliances of the vendors in the market, resulting in consolidation to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. The Global Pediatric Vaccine market is expected to grow at a CAGR of 10.25 percent during the period 2013-2018.
Pediatric vaccines are used for the immunization of children to give protection against infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases.
“Inclusion of pediatric vaccination in national immunization programs increases the accessibility of vaccines to low-income families,” says Faisal Ghaus, Vice President of TechNavio Research.
“Various governments conduct routine immunization schedules to ensure that vaccines are available to children. This, in turn, increases the consumption of vaccines at the national level. Recommended vaccines and doses are regularly updated to comply with the prevalent serogroups of infectious agents.
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
